People In Brief
This article was originally published in The Tan Sheet
Executive Summary
Bayer vet Durkee takes on Schiff R&D role
You may also be interested in...
In Brief
Acura delays Nexafed post meth studies
People In Brief
NOW Foods adds Secrist to QA roster
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.